Skip to main content
logo
Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
30.00
+0.68 (2.32%)
At close: Oct 7, 2026, 4:00 PM EDT
30.01
0.00 (0.02%)
After-hours: Oct 7, 2026, 7:30 PM EDT

LKFT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,9292,1661,8092,6942,9093,669
Market Cap Growth
-17.67%19.74%-32.85%-7.39%-20.71%-43.02%
Enterprise Value
-571-1,406-1,635-1,503-1,728-1,844
Last Close Price
30.0032.7027.5040.6544.3855.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.835.7523.5911.51--
PS Ratio
1.701.666.3410.1711.2813.77
PB Ratio
0.520.570.600.871.081.22
P/TBV Ratio
0.670.570.660.941.171.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010.01
Debt / EBITDA Ratio
0.010.01----
Net Debt / Equity Ratio
-0.68-0.92-1.07-1.31-1.61-1.77
Net Debt / EBITDA Ratio
-3.92-5.2620.2688.6162.1828.64
Net Debt / FCF Ratio
9.6511.039.228.657.718.38
Asset Turnover
0.280.300.070.050.050.04
Inventory Turnover
15.1613.285.923.807.3430.64
Quick Ratio
32.6519.969.578.767.988.53
Current Ratio
32.8420.159.979.028.118.58
Return on Equity (ROE)
20.12%10.42%-0.04%-0.15%-2.76%-4.55%
Return on Assets (ROA)
9.93%8.87%-2.75%-1.17%-1.65%-1.97%
Return on Invested Capital (ROIC)
87.08%2988.46%----
Return on Capital Employed (ROCE)
17.40%16.50%-4.90%-2.20%-3.10%-3.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
35.34%17.39%4.24%8.69%-8.01%-3.20%
FCF Yield
-13.44%-14.70%-19.27%-17.42%-19.39%-17.29%
Buyback Yield / Dilution
-0.05%0.06%-0.01%-0.36%-0.30%-0.65%
SEC Filings: 10-K · 10-Q